Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04090424 · ClinicalTrials.gov registry record · NA
Assessment of Safety and Effectiveness of NovoSorb® BTM in Severe Burns
A NA study of Burns, sponsored by PolyNovo Biomaterials Pty.
- Active
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 20
- Study locations
NCT04090424 is a NA study of Burns that is active but no longer recruiting, run by PolyNovo Biomaterials Pty. The registered enrollment target is 150 participants, above the 79-participant average among 36 other Burns trials with a reported enrollment target (90% higher). The trial reports 20 study locations across 15 states.
The verdict
NCT04090424, a NA study of Burns, is active but no longer recruiting, sponsored by PolyNovo Biomaterials Pty.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a multi-center, pivotal study to assess the safety and effectiveness of a new method of treating severe burns using NovoSorb® Biodegradable Temporizing Matrix (BTM).
Conditions Studied
Interventions
- PROCEDURE Standard of Care
- DEVICE NovoSorb BTM
Study Locations (20)
California
- Southern California Regional Burn Center at LAC+USC - Los Angeles
- University of California Davis Medical Center - Sacramento
Massachusetts
- Brigham and Women's Hospital - Boston
- Massachusetts General Hospital - Boston
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
- Wake Forest Baptist Health - Winston-Salem
Ohio
- Akron Children's Hospital, Burn Center - Akron
- The Ohio State University/ Wexner Medical Center - Columbus
Pennsylvania
- Lehigh Valley Hospital and Health Network - Allentown
- Temple University Hospital - Philadelphia
Arizona
- Valleywise Health - Phoenix
Connecticut
- Bridgeport Hospital - Bridgeport
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2021-09-21 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04090424
The ClinicalTrials.gov registry entry for NCT04090424 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 79-participant average among 36 other Burns trials with a reported enrollment target (90% higher). The listed sponsor is PolyNovo Biomaterials Pty, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Burns appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT04090424 reports 20 study locations spanning 15 distinct geographic areas - top geographies include California, Massachusetts, North Carolina.
Frequently Asked Questions
What is clinical trial NCT04090424 about?
NCT04090424 is a clinical study titled "Assessment of Safety and Effectiveness of NovoSorb® BTM in Severe Burns". This is a multi-center, pivotal study to assess the safety and effectiveness of a new method of treating severe burns using NovoSorb® Biodegradable Temporizing Matrix (BTM).
What is the current status of trial NCT04090424?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2021-09-21. Estimated completion is 2026-12.
What conditions does trial NCT04090424 study?
This clinical trial studies the following conditions: Burns.
What interventions are being tested in trial NCT04090424?
The interventions under investigation include: Standard of Care (PROCEDURE), NovoSorb BTM (DEVICE).
Who is sponsoring clinical trial NCT04090424?
This trial is sponsored by PolyNovo Biomaterials Pty, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04090424 being conducted?
This trial has 20 study locations across Arizona, California, Connecticut, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Burns
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Suprathel® Use During Prolonged Field Care to Promote Healing and Reduce the Need for Grafting of Burn Wounds
RECRUITING · NA
-
Impact of a Telerehabilitation Program With Technology Enhancement on Post-burn Recovery
RECRUITING · NA
-
Conditioning & Open-Label Placebo (COLP) for Opioid Management in Intensive Inpatient Rehabilitation
ACTIVE NOT RECRUITING · NA
-
Virtual Reality in Burn Pain Management
COMPLETED · NA
-
Randomized Control Trial of CO2 Laser to Treat Hypertrophic Burn Scar
COMPLETED · NA
-
VR for Pain Management During Adult Burn Dressing Change
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.